Pillstats
Rx only · Tablet, Extended Release · Oral

Levetiracetam

Brands: Elepsia Xr 1000 Mg · Elepsia Xr 1500 Mg · Levetiracetam

5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
5 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)114477
US makers5 labelers
Packages23
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.064$0.128$0.191$0.255Dec 2025Apr 2026Jul 2026
$0.195
Latest avg · Jul 22, 2026
-12%
Since Dec 17, 2025
5
Active US suppliers
65%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

11K22K33K44K2025 Q12025 Q22025 Q32025 Q42026 Q1
37K
Rx · 2026 Q1
4.6M
Units dispensed
+18%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it5 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Torrent Pharmaceuticals Limitedunknown9SUPPLYING
TRIPOINT THERAPEUTICS, LLCunknown6SUPPLYING
Omnivium Pharmaceuticals LLCunknown4SUPPLYING
Lupin Pharmaceuticals,Inc.unknown2SUPPLYING
BluePoint Laboratoriesunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.